Resolving crossmatch incompatibility due to daratumumab in multiple myeloma
Daratumumab (DARA) is an anti-CD38 monoclonal antibody which has promising results in relapsed and refractory multiple myeloma. DARA interferes with blood compatibility testing by causing panagglutination in the indirect antiglobulin test. In all incompatibilities, immunohematology workup must be do...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wolters Kluwer Medknow Publications
2020-01-01
|
| Serie: | Global Journal of Transfusion Medicine |
| Soggetti: | |
| Accesso online: | http://www.gjtmonline.com/article.asp?issn=2468-8398;year=2020;volume=5;issue=2;spage=225;epage=227;aulast=Anuragaa |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|